Presented at the international conference of the European Association for Behavioural and Cognitive Therapies TOKYO, Sept. 17, 2021– Jolly Good and...
Medical
~Initiative by Jolly Good and Nippon Medical School~ TOKYO, Sept. 2, 2021 — At many Japanese institutions offering medical education, medical students...
WHO Goodwill Ambassador for Leprosy Elimination 20th Anniversary Advocacy Campaign TOKYO, July 28, 2021 — Sasakawa Leprosy...
TOKYO, May 24, 2021 — Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem. Today...
TOKYO, April 22, Japan — Jolly Good Inc. (“Jolly Good”) and Teijin Pharma Ltd. (“Teijin Pharma”) have signed a business...